Ugurel S - Search Results

1

S1-Guideline Cutaneous Angiosarcomas - Update 2021.

Vogt T, Müller CSL, Melchior P, Rübe C, Ugurel S, Schimming TT, Utikal J, Esser S, Helbig D, Hadaschik E, Kasper B, Grabbe S. Vogt T, et al. Among authors: ugurel s. J Dtsch Dermatol Ges. 2021 Dec;19(12):1801-1812. doi: 10.1111/ddg.14524. Epub 2021 Nov 25. J Dtsch Dermatol Ges. 2021. PMID: 34821470 No abstract available.

2

[90-year-old male with a hyperkeratotic lichenoid skin eruption].

Bauer U, Ugurel S, Utikal J, Schadendorf D, Goerdt S. Bauer U, et al. Among authors: ugurel s. J Dtsch Dermatol Ges. 2005 Feb;3(2):137-9. doi: 10.1111/j.1610-0378.2005.04082.x. J Dtsch Dermatol Ges. 2005. PMID: 16351017 German. No abstract available.

3

Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study.

Schadendorf D, Hauschild A, Ugurel S, Thoelke A, Egberts F, Kreissig M, Linse R, Trefzer U, Vogt T, Tilgen W, Mohr P, Garbe C. Schadendorf D, et al. Among authors: ugurel s. Ann Oncol. 2006 Oct;17(10):1592-7. doi: 10.1093/annonc/mdl148. Ann Oncol. 2006. PMID: 17005632 Free article. Clinical Trial.

4

Local cutaneous argyria mimicking melanoma metastases in a patient with disseminated melanoma.

Utikal J, Thoelke A, Becker JC, Figl R, Goerdt S, Schadendorf D, Ugurel S. Utikal J, et al. Among authors: ugurel s. J Am Acad Dermatol. 2006 Nov;55(5 Suppl):S92-4. doi: 10.1016/j.jaad.2005.10.062. J Am Acad Dermatol. 2006. PMID: 17052544 No abstract available.

5

Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies.

Utikal J, Schadendorf D, Ugurel S. Utikal J, et al. Among authors: ugurel s. Arch Dermatol Res. 2007 Mar;298(10):469-77. doi: 10.1007/s00403-006-0726-5. Arch Dermatol Res. 2007. PMID: 17221215 Free PMC article. Review.

6

[Targeted therapy of dermatofibrosarcoma with imatinib].

Ugurel S. Ugurel S. J Dtsch Dermatol Ges. 2007 Mar;5(3):261. doi: 10.1111/j.1610-0387.2007.07009.x. J Dtsch Dermatol Ges. 2007. PMID: 17338806 German. No abstract available.

7

Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses.

Utikal J, Ugurel S, Kurzen H, Erben P, Reiter A, Hochhaus A, Nebe T, Hildenbrand R, Haberkorn U, Goerdt S, Schadendorf D. Utikal J, et al. Among authors: ugurel s. Arch Dermatol. 2007 Jun;143(6):736-40. doi: 10.1001/archderm.143.6.736. Arch Dermatol. 2007. PMID: 17576939

8

Strategies to optimize the use of targeted agents for tumor therapy.

Becker JC, Ugurel S, Schrama D. Becker JC, et al. Among authors: ugurel s. J Dtsch Dermatol Ges. 2008 Apr;6(4):281-5. doi: 10.1111/j.1610-0387.2008.06496.x. Epub 2008 Jan 17. J Dtsch Dermatol Ges. 2008. PMID: 18205839 Review. English, German.

9

Skin toxicity of anti-cancer therapy.

Ulrich J, Hartmann JT, Dörr W, Ugurel S. Ulrich J, et al. Among authors: ugurel s. J Dtsch Dermatol Ges. 2008 Nov;6(11):959-77. doi: 10.1111/j.1610-0387.2008.06831.x. J Dtsch Dermatol Ges. 2008. PMID: 18992037 Review. English, German.

10

Merkel cell carcinoma: molecular pathogenesis, clinical features and therapy.

Becker JC, Kauczok CS, Ugurel S, Eib S, Bröcker EB, Houben R. Becker JC, et al. Among authors: ugurel s. J Dtsch Dermatol Ges. 2008 Sep;6(9):709-19. doi: 10.1111/j.1610-0387.2008.06830.x. J Dtsch Dermatol Ges. 2008. PMID: 19000060 Review. English, German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

303 results

Search Page